Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Latest news/
      3. Innovation/
      4. Innovation-opedia: What is a mosaic vaccine?
      Graphic featuring a syringe to illustrate an HIV vaccine trial
      Innovation

      Innovation-opedia: What is a mosaic vaccine?

      As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

      Written by Johnson & Johnson
       | July 22, 2019
      July 22, 2019
      Illustrated handwritten definition of a mosaic HIV vaccine
      Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
      Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
      Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
      Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

      We’re committed to helping lead the fight against HIV/AIDS

      Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
      Learn more
      CTA-Red ribbon HIV

      HIV vaccine HIV/AIDS J&J Innovative Medicine Johnson & Johnson

      More from Johnson & Johnson

      A visual representation connected to IBD treatment advancements in 2025, emphasizing innovation and progress in therapies for inflammatory bowel disease
      Innovation
      March 10, 2025

      Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

      Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
      Read more
      Illustration of innovative autoimmune disease treatment using monoclonal antibodies, advancing immune system research
      Innovation
      March 3, 2025

      The future of immunology

      Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.
      Read more
      An image of colorectal cancer (left) and colitis (right), which can raise your risk of developing colorectal cancer
      Health & wellness
      February 27, 2025

      5 things we now know about colorectal cancer

      Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.
      Read more